NSE/BIOCON (NSE/BIOCON)

National Stock Exchange of India: NSE/BIOCON · INR

₹351

+18.25 (+5.5%)· Recorded snapshot

Market cap	571B
Revenue (ttm)	173.2B
Net income (ttm)	5B
EPS (ttm)	₹3.37
Shares out	1.6B
P/E (trailing)	104.2x
P/E (forward)	71.3x
Dividend	₹0.50 (0.14%)
Volume	4,293,502
Beta	0.32

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 173.2B
Net income (ttm): 5B
EPS (ttm): ₹3.37
P/E (trailing): 104.2x
P/E (forward): 71.3x
Market cap: 571B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E71.3

P25 n/aP50 n/aP75 n/a

Trailing P/E104.2

P25 n/aP50 n/aP75 n/a

ROE1.1

P25 n/aP50 n/aP75 n/a

ROIC3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NSE/BIOCON indicators

Market & fundamental data

Available fields

256

Groups with data

Currency

INR

Showing 256 of 256 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-04
Employees	16,447
Employees change	132
Employees growth	0.81%
Enterprise value	INR 712.4B
Exchange	National Stock Exchange of India
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1978
Industry	Biotechnology
Is primary listing	Yes
ISIN number	INE376G01013
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2019-06-12
Last stock split type	Forward
Market cap	INR 571B
Next earnings date	2026-11-04
Price	INR 350.70
Price currency	INR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	nse/BIOCON
Website	https://www.biocon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	61.71x
Average P/E ratio (10Y)	61.49x
Average P/E ratio (3Y)	72.1x
Average P/E ratio (5Y)	68.82x
Earnings yield	0.96%
EV/Earnings	143.84x
EV/EBIT	42.33x
EV/EBITDA	19.51x
EV/FCF	363.31x
EV/Sales	4.11x
FCF / EV yield	0.28%
FCF yield	0.34%
Forward P/E	71.28x
Graham number	126.16952
Graham upside	-64.02%
Industry forward P/E	42.91x
Industry P/E	95.02x
Lynch fair value	INR 16.83
Lynch upside	-95.2%
P/(FCF - SBC) ratio	1,773.42x
P/(OCF - SBC) ratio	31.2x
P/B ratio	1.56x
P/E ratio	104.16x
P/FCF ratio	291.2x
P/OCF ratio	28.64x
P/S ratio	3.3x
PEG ratio	1.16x
Price / tangible book value	10.93x
Price/EBITDA ratio	15.94x
Sector forward P/E	36.12x
Sector P/E	45.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.72%
EBITDA margin	20.69%
Effective tax rate	13%
FCF margin	1.16%
Gross margin	61.19%
Operating margin	9.72%
Pretax margin	2.76%
Profit margin	2.86%
Profit per employee	INR 301,149
Profitable quarters	7
Profitable years	23
Revenue per employee	INR 10.5M
ROA	1.73%
ROA (5Y)	2.38%
ROCE	3.42%
ROE	1.15%
ROE (5Y)	4.92%
ROIC	3.04%
ROIC (5Y)	4.63%
SBC / revenue	0.97%
Tax / revenue	0.36%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	4.95%
EPS growth (Q)	234.62%
EPS growth (QoQ)	10.13%
EPS growth 10Y	-8.08%
EPS growth 3Y	-1.39%
EPS growth 5Y	-9.85%
EPS growth quarters	1
EPS growth years	0
FCF growth	-89.81%
FCF growth 3Y	-8.56%
Gross profit growth	11.2%
Gross profit growth (Q)	13.07%
Gross profit growth 3Y	11.05%
Gross profit growth 5Y	18.67%
Net income growth	28.65%
Net income growth (Q)	349.36%
Net income growth (QoQ)	12.07%
Net income growth 3Y	5.68%
Net income growth 5Y	-6.02%
Net income growth quarters	1
Net income growth years	0
OCF growth	-50.9%
OCF growth 10Y	18.33%
OCF growth 3Y	2.48%
OCF growth 5Y	11.45%
Operating income growth	3.76%
Operating income growth (Q)	2.01%
Operating income growth 3Y	-1.08%
Operating income growth 5Y	13.29%
Revenue growth	9.83%
Revenue growth (Q)	10%
Revenue growth (QoQ)	-4%
Revenue growth 10Y	16.84%
Revenue growth 3Y	11.61%
Revenue growth 5Y	19.28%
Revenue growth quarters	6
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -18B
Depreciation and amortization	INR 19B
EBIT	INR 16.8B
EBITDA	INR 35.8B
EPS	INR 3.37
FCF per share	INR 1.20
Financing cash flow	INR -9.2B
Free cash flow	INR 2B
Free cash flow minus SBC	INR 322M
Gross profit	INR 106B
Income taxes	INR 622M
Investing cash flow	INR -20.8B
Net borrowing	INR -46.7B
Net cash flow	INR -8.1B
Net income	INR 5B
Operating cash flow minus SBC	INR 18.3B
Operating income	INR 16.8B
Revenue	INR 173.2B
Stock-based compensation	INR 1.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 210.14
Debt / EBITDA	4.23
Debt / equity	0.42
Debt / FCF	78.71
Interest coverage	1.87
Net cash (debt)	INR -115.5B
Net cash / market cap	-20.23%
Net debt / EBITDA	3.22
Net debt / equity	0.32
Net debt / FCF	58.9
Piotroski F-Score	7
Shareholders' equity	INR 366.2B
Tangible book value	INR 52.2B
Tangible book value per share	INR 32.25
Total cash	INR 38.8B
Total debt	INR 154.3B
WACC	5.81%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.28
Current ratio	1.22
Inventory turnover	1.21
Quick ratio	0.71
Working capital	INR 31.1B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-22.59%
Dividend growth	0%
Dividend growth (10Y)	-4.98%
Dividend growth (3Y)	-30.66%
Dividend growth (5Y)	0%
Dividend growth years	0
Dividend payment date	2026-08-20
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	INR 0.50
Dividend yield	0.14%
Ex-dividend date	2026-07-03
FCF payout ratio	41.52%
Last dividend	INR 0.50
Payout ratio	14.85%
Shareholder yield	-22.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	128.51%
10Y return CAGR	8.81%
10Y total return	132.5%
150-day SMA	INR 395.18
15Y price change	493.4%
15Y return CAGR	13.32%
15Y total return	552.57%
1D price change	5.49%
1M price change	-8.23%
1M total return	-8.23%
1W price change	3.15%
1W total return	3.15%
1Y price change	-2.7%
1Y return CAGR	-2.59%
1Y total return	-2.59%
20-day SMA	INR 350.31
200-day SMA	INR 391.07
20Y price change	1,023.28%
20Y return CAGR	13.72%
20Y total return	1,207.49%
3M price change	-19.61%
3M total return	-19.61%
3Y price change	57.48%
3Y return CAGR	16.49%
3Y total return	58.09%
50-day SMA	INR 379.40
50-day SMA vs 200-day SMA	50under200
52-week high	INR 447.15
52-week high date	2026-07-16
52-week low	INR 318.40
52-week low date	2026-10-23
5Y price change	3.85%
5Y return CAGR	0.99%
5Y total return	5.03%
6M price change	-3.12%
6M total return	-3.01%
All-time high	INR 487.75
All-time high date	2020-12-23
All-time low	INR 14.17
All-time low date	2008-12-02
Average true range (ATR)	INR 9.52
Average volume	2.8M
Beta (1Y)	0.07
Beta (2Y)	0.26
Beta (5Y)	0.32
Change from 52-week high	-21.57%
Change from 52-week low	10.14%
Change from all-time high	-28.1%
Change from all-time low	2,375.47%
Change from open	5.81%
Day's gap	-0.3%
Dollar volume	INR 1.5B
High price	INR 350.70
Low price	INR 330.60
Monthly RSI	47.58
Open price	INR 331.45
Position in 52-week range	100%
Previous close	INR 332.45
Price vs 150-day SMA	-11.26%
Price vs 20-day SMA	0.11%
Price vs 200-day SMA	-10.32%
Price vs 50-day SMA	-7.56%
Relative volume	1.54
RSI	45.94
Sharpe ratio	-0.17
Sharpe ratio (3Y)	0.36
Sharpe ratio (5Y)	0.02
Sortino ratio	-0.02
Sortino ratio (3Y)	0.71
Sortino ratio (5Y)	0.21
Volume	4.3M
Weekly RSI	38.3
YTD price change	-10.97%
YTD total return	-10.86%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	823.8M
Shares change (QoQ)	1.77%
Shares change (YoY)	22.59%
Shares held by insiders	44.91%
Shares held by institutions	26.64%
Shares outstanding	1.6B

Deeper analysis on NSE/BIOCON

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NSE/BIOCON report

Is a complete NSE/BIOCON research report available?

No complete published report is available for nse/BIOCON (NSE/BIOCON) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/BIOCON (NSE/BIOCON)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/BIOCON

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/BIOCON indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NSE/BIOCON

Frequently asked questions